3,871 results on '"Cystic fibrosis"'
Search Results
2. Chronic Illness in Adolescents: A Sociological Perspective.
3. Royalty Pharma price target lowered by $20 at Citi, here's why
4. Vertex Pharmaceuticals price target raised by $85 at UBS, here's why
5. Vertex Pharmaceuticals initiated with neutral view at Scotiabank, here's why
6. Vertex Pharmaceuticals price target lowered by $9 at BofA, here's why
7. Vertex Pharmaceuticals resumed with a Market Perform at Raymond James
8. Insmed price target raised by $2 at BofA, here's why
9. University of Verona Researchers Publish New Data on Orphan Drugs (CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids)
10. Sophie Grace Holmes
11. Arcturus Therapeutics Highlights Clearance of an Investigational New Drug Application to U.S. FDA for ARCT-032
12. Biology opens up new frontiers in medicine to cure genetic diseases: Kiran Mazumdar Shaw
13. Claire's Place Foundation to Host 10th Annual Glow Ride for Cystic Fibrosis
14. Arcturus Therapeutics Gets Clearance of an Investigational New Drug Application to U.S. FDA for ARCT-032
15. Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?
16. Nutrition Interventions for Pancreatic Insufficiency.
17. Researchers Submit Patent Application, 'Polynucleotides Encoding Cystic Fibrosis Transmembrane Conductance Regulator For The Treatment Of Cystic Fibrosis', for Approval (USPTO 20240238210)
18. Data on Life Science Reported by Researchers at Telethon Institute of Genetics and Medicine TIGEM (Anoctamin Pharmacology)
19. Royalty Pharma reports Q2 revenue $537M, consensus $628.52M
20. Vertex Pharmaceuticals just downgraded at Barclays, here's why
21. Vertex Pharmaceuticals price target raised by $50 at Oppenheimer, here's why
22. LasR regulates protease IV expression at suboptimal growth temperatures in Pseudomonas aeruginosa
23. Research and Marketa Brings Out Report: Cystic Fibrosis Therapeutics Market 2024-2032
24. Vertex Pharmaceuticals price target raised by $53 at Morgan Stanley, here's why
25. Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
26. Scientists map how deadly bacteria evolved to become epidemic
27. Arcturus Therapeutics updates on OTC deficiency in CF programs
28. Insmed price target raised by $17 at JPMorgan, here's why
29. Vertex Pharmaceuticals price target raised by $85 at Argus, here's why
30. Vertex Pharmaceuticals price target lowered by $3 at RBC Capital, here's why
31. Arcturus Therapeutics weakness after CF data 'overblown,' says William Blair
32. Vertex Pharmaceuticals presents new data at ECFS on TRIKAFTA treatment
33. 4D Molecular presents interim data from Phase 1/2 AEROW trial
34. Bioversys receives non-dilutive funding from CF AMR Syndicate Collaborative Discovery Programme
35. CRISPR lung treatment offers hope for cystic fibrosis.
36. Arcturus Therapeutics reports positive development for Cystic Fibrosis program
37. Krystal Biotech to present preclinical data on KB407, KB408
38. Vertex announces European Commission approval for KALYDECO
39. 4D Molecular price target raised by $5 at RBC Capital, here's why
40. 4D Molecular assumed with a Buy at Jefferies
41. 4D Molecular announce update on regulatory interactions, development for 4D-710
42. Data on Pseudomonas aeruginosa Described by Researchers at East Carolina University (Advances in Development of Novel Therapeutic Strategies against Multi-Drug Resistant * * Pseudomonas aeruginosa* *)
43. Krankenversicherung: Einschließlich Pflegeversicherung und Beitragsrecht der Kranken-, Renten- und Arbeitslosenversicherung.
44. EC grants orphan medicinal product designation to Arcturus Therapeutics' ARCT-032 to treat cystic fibrosis
45. Patent Application Titled 'Polynucleotides Encoding Cystic Fibrosis Transmembrane Conductance Regulator For The Treatment Of Cystic Fibrosis' Published Online (USPTO 20230406895)
46. Studies from University of Iowa Describe New Findings in Science (Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo)
47. Vertex: EMA Validates Marketing Authorization Application Extension for KAFTRIO in Combination with Ivacaftor
48. Researchers' Work from University of Rouen Normandy Focuses on Pseudomonas aeruginosa (High Affinity Iron Uptake By Pyoverdine In pseudomonas Aeruginosa Involves Multiple Regulators Besides Fur, Pvds, and Fpvi)
49. McGill University Researchers Publish New Data on Science (Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain-domain coupling)
50. Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain-domain coupling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.